1. Home
  2. LODE vs MIST Comparison

LODE vs MIST Comparison

Compare LODE & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

N/A

Current Price

$2.27

Market Cap

171.0M

Sector

Industrials

ML Signal

N/A

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

N/A

Current Price

$0.82

Market Cap

146.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LODE
MIST
Founded
1999
2003
Country
United States
Canada
Employees
45
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.0M
146.9M
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
LODE
MIST
Price
$2.27
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $5.86
AVG Volume (30 Days)
1.2M
★ 1.4M
Earning Date
10-29-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.55
N/A
EPS
N/A
★ N/A
Revenue
★ $1,553,796.00
N/A
Revenue This Year
$303.79
$147.62
Revenue Next Year
$410.04
$476.43
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.23
$0.75
52 Week High
$4.98
$3.06

Technical Indicators

Market Signals
Indicator
LODE
MIST
Relative Strength Index (RSI) 27.65 40.29
Support Level N/A N/A
Resistance Level $3.61 $1.42
Average True Range (ATR) 0.17 0.06
MACD -0.02 -0.00
Stochastic Oscillator 17.21 46.38

Price Performance

Historical Comparison
LODE
MIST

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Share on Social Networks: